Stay up to date with the most recent announcements from the media

Lifesciences

Techcircle

Jul 2, 2021

Eyestem is breaking cell therapy price barrier and its first target is an incurable eye disease

Bengaluru based Eyestem has set its sight on finding an affordable cure for an incurable eye disease – dry age-related macular degeneration (AMD) – the first of many conditions it wants to treat using a unique cell therapy platform.

Fintech

Moneycontrol

Jul 2, 2021

New generation of investors started in a bull market and that isn’t a great teacher: Kanika Agarrwal of Upside AI

Kanika Agarrwal, co-founder and chief investment officer, Upside AI, is of the view that the new generation of equity investors has a lot to learn. They started in a bull market and that isn’t a great teacher, she says.

Enterprise

Indian Express

Jun 29, 2021

Beyond Alexa: This startup wants to bring multilingual voice assistants to apps

Voice is the new UI. Slang lab's Conva set to help consumers in e-commerce, travel, insurance, & recruitment with voice assistance in Indian languages empowering Indian consumers.

Digital Health

Yourstory

Jun 24, 2021

Synapsica Healthcare raises $4.2M from IvyCap Ventures and Endiya Partners for global expansion

Synapsica Healthcare is creating India's first integrated platform to use AI for automation of both clinical and back-office tasks in radiology.

No items found.

News

Eyestem is breaking cell therapy price barrier and its first target is an incurable eye disease

New generation of investors started in a bull market and that isn’t a great teacher: Kanika Agarrwal of Upside AI

Beyond Alexa: This startup wants to bring multilingual voice assistants to apps

Synapsica Healthcare raises $4.2M from IvyCap Ventures and Endiya Partners for global expansion